CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 1,028 enrolled
Drug / intervention
Tramadol Once a day +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00833794
NCT00833794Phase 3Completed
CompareCT.gov

A Two-Arm Study Comparing the Analgesic Efficacy and Safety of Tramadol HCl Once-a-Day Versus Placebo for the Treatment of Pain Due to Osteoarthritis

Labopharm Inc.·interventional·Posted Feb 2, 2009·Updated Apr 30, 2012

In Brief

A Phase 3 clinical trial evaluating Tramadol Once a day and Placebo for Pain and Osteoarthritis. Completed, enrolled 1,028 participants.

Detailed Summary

The purpose of this study is to compare the analgesic efficacy, safety and clinical benefit of Tramadol OAD tablets versus Placebo.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Osteoarthritis
Countries--
Collaborators--

Timeline

Phase 3CompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 2, 2009
Enrollment StartOct 1, 2004
Primary CompletionJan 1, 2006
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 17.4 years ago

Interventions

Tramadol Once a daydrug

Placebodrug